Published in Clin Exp Immunol on May 01, 1990
Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae. Infect Immun (1993) 1.14
Cellular immune responses to recombinant heat shock protein 70 from Histoplasma capsulatum. Infect Immun (1996) 0.97
The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses. Infect Immun (1992) 0.92
Analysis of B-cell epitopes in the variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein. Infect Immun (1993) 0.89
Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. Infect Immun (1997) 0.85
Identification of human T cell epitopes in the Mycobacterium leprae heat shock protein 70-kD antigen. Clin Exp Immunol (1993) 0.83
Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls. Clin Exp Immunol (1994) 0.83
Lack of cytotoxic activity against Mycobacterium leprae 65-kD heat shock protein (hsp) in multibacillary leprosy patients. Clin Exp Immunol (1995) 0.82
Nerve and skin damage in leprosy is associated with increased intralesional heat shock protein. Clin Exp Immunol (1994) 0.79
Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae. Clin Diagn Lab Immunol (2001) 0.78
The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest (1968) 10.35
Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin Exp Immunol (1973) 4.12
Single step separation of human T and B cells using AET treated srbc rosettes. J Immunol Methods (1976) 3.41
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Immunological study of the defined constituents of mycobacteria. Springer Semin Immunopathol (1988) 1.28
Differential effect of cigarette smoking on recirculating T lymphocyte subsets in pregnant women. J Immunol (1986) 1.12
Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Clin Exp Immunol (1987) 1.11
Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol (1987) 1.04
Lymphocyte antigenicity loss with retention of responsiveness. Science (1974) 0.92
Use of phenolic glycolipid 1 for serodiagnosis of leprosy in a high prevalence village in Papua New Guinea. Trans R Soc Trop Med Hyg (1987) 0.88
A simplified serological test for leprosy based on a 3,6-di-O-methylglucose-containing synthetic antigen. Am J Trop Med Hyg (1986) 0.85
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med (1999) 3.30
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc Natl Acad Sci U S A (1983) 2.90
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
A man who pricked his finger and smelled putrid for 5 years. Lancet (1996) 2.03
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96
Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94
Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75
Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J (1971) 1.66
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Specific collaboration between T and B lymphocytes across a cell impermeable membrane in vitro. Nat New Biol (1972) 1.49
Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood (1970) 1.48
Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndrome. J Neurol Sci (2010) 1.47
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45
Part one: All major arterial interventions should now be performed in high volume centres--abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2011) 1.42
Hand venous hypertension complicating arterio-venous fistula construction for haemodialysis. Clin Exp Dermatol (1989) 1.39
Front-line GPs wanted. Aust Fam Physician (1994) 1.38
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31
High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: methodology and preliminary observations. Ther Drug Monit (1982) 1.31
Evaluation of a cognitive-behavioural intervention for HIV prevention among injecting drug users. AIDS (1993) 1.26
Humoral and cell mediated responses in vitro of spleen cells from mice with thymic aplasia (nude mice). Aust J Exp Biol Med Sci (1972) 1.26
Severe salmonella infection in patients with reduced gastric acidity. Practitioner (1985) 1.25
The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepr Rev (1986) 1.24
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood (1992) 1.22
Immune complexes in early arthritis. L Detection of immune complexes before rheumatoid arthritis is definite. Clin Exp Immunol (1981) 1.21
Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20
Amiodarone in testis and semen. Lancet (1985) 1.20
Images in cardiology. Near miss paradoxical embolism. Br Heart J (1994) 1.20
B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS (2000) 1.20
HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19
Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer (1975) 1.18
Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci U S A (1990) 1.17
Tampon-associated toxic shock syndrome. Br Med J (1980) 1.17
Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16
Evidence for a general neurotic syndrome. Br J Psychiatry (1990) 1.15
B cell life span: a review. Immunol Cell Biol (1997) 1.15
Suppressor cells in humoral immunity and tolerance. Br Med Bull (1976) 1.14
Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med (1983) 1.14
Influences on the lifespan of B cell subpopulations defined by different phenotypes. Eur J Immunol (1997) 1.14
Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13
Cell interactions in the immune response in vitro. I. Metabolic activities of T cells in a collaborative antibody response. Eur J Immunol (1972) 1.13
The need for central and peripheral tolerance in the B cell repertoire. Science (1990) 1.12
B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol (1995) 1.12
Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A (1994) 1.11
Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol (1977) 1.10
Suppressor T-cell memory. Nature (1978) 1.10
Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc Natl Acad Sci U S A (1991) 1.09
Immune complexes in thrombocytopenic patients: cause or effect? Br J Haematol (1980) 1.09
Immune function in aged mice. IV. Loss of T cell and B cell function in thymus-dependent antibody responses. Eur J Immunol (1978) 1.09
Post-mammoplasty connective tissue disease. Arthritis Rheum (1982) 1.08
Determination of selenium in biological samples by hydride generation and atomic-absorption spectroscopy. Analyst (1982) 1.07
Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients. Clin Exp Immunol (1988) 1.05
Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol (1987) 1.04
Mechanisms of tolerance to self. Curr Opin Immunol (1996) 1.04
Loss of immune competence with age may be due to a qualitative abnormality in lymphocyte membranes. Nature (1979) 1.03
Individuals from different populations identify multiple and diverse T-cell determinants on mycobacterial HSP70. Scand J Immunol (1994) 1.03
Molecular genetics of small bowel cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.03
Suppressor T cells in tolerance to non-self and self antigens. Cold Spring Harb Symp Quant Biol (1977) 1.03
The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1. Eur J Biochem (1997) 1.01
Microbial exposure, interferon gamma gene demethylation in naïve T-cells, and the risk of allergic disease. Allergy (2009) 1.00
Selective cytotoxicity of anti-kappa serum for B lymphocytes. Nat New Biol (1972) 0.98
HLA-DW2, viral immunity and family studies in multiple sclerosis. J Neurol Sci (1977) 0.97
Labour-saving strategies to maintain survey response rates: a randomised trial. Aust N Z J Public Health (1998) 0.96
Complementary relationship between repetitive sequences in the SV40 early gene pre-promoter enhancing region and big-T antigen splice junction exons. J Theor Biol (1984) 0.96
Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol (1980) 0.95
Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J Exp Med (1998) 0.95
What are killer cells and what do they do? Blood Rev (1988) 0.94
Staphylococcal enterotoxin induced IL-5 stimulation as a cofactor in the pathogenesis of atopic disease: the hygiene hypothesis in reverse? Allergy (2003) 0.93